{
  "title": "Neurological and Psychiatric Sequelae Due to COVID-19",
  "itunes:title": "Neurological and Psychiatric Sequelae Due to COVID-19",
  "pubDate": "Sun, 06 Feb 2022 17:00:26 +0000",
  "guid": "024098f8-6734-4e4c-b4bd-a3cf535fe0fb",
  "link": "https://psychopharmacology.libsyn.com/neurological-and-psychiatric-sequelae-due-to-covid-19",
  "itunes:image": "",
  "description": "<p>COVID-19 infection is associated with new-onset neurological illness but at relatively low absolute rates. On the other hand, rates for new-onset anxiety and mood disorders can be higher, at 7% and 8%, respectively. </p> <p>Faculty: Jim Phelps, M.D. <br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC139\"> <strong>Learn more about our memberships here</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-31-2612?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC139\"> <strong>Earn 0.5 CMEs: Quick Take Vol. 31</strong></a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/six-month-neurological-and-psychiatric-outcomes-in-236379-survivors-of-covid-19-a-retrospective-cohort-study-using-electronic-health-records-2612-5097?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC139\"> <strong>Six-Month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health Records</strong></a></li> </ul>",
  "content:encoded": "<p>COVID-19 infection is associated with new-onset neurological illness but at relatively low absolute rates. On the other hand, rates for new-onset anxiety and mood disorders can be higher, at 7% and 8%, respectively. </p> <p>Faculty: Jim Phelps, M.D.  Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= \"https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC139\"> Learn more about our memberships here</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/publication/quick-take-vol-31-2612?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC139\"> Earn 0.5 CMEs: Quick Take Vol. 31</a></li> <li><a href= \"https://psychopharmacologyinstitute.com/section/six-month-neurological-and-psychiatric-outcomes-in-236379-survivors-of-covid-19-a-retrospective-cohort-study-using-electronic-health-records-2612-5097?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC139\"> Six-Month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19: A Retrospective Cohort Study Using Electronic Health Records</a></li> </ul>",
  "enclosure": "",
  "itunes:duration": "08:32",
  "itunes:explicit": false,
  "itunes:keywords": "",
  "itunes:subtitle": "COVID-19 infection is associated with new-onset neurological illness but at relatively low absolute rates. On the other hand, rates for new-onset anxiety and mood disorders can be higher, at 7% and 8%, respectively.  Faculty: Jim Phelps,...",
  "itunes:episodeType": "full"
}